These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9598656)

  • 1. The use of salivary stimulant pastilles to improve compliance in women taking oxybutinin hydrochloride for detrusor instability.
    Arango O
    Br J Urol; 1998 Apr; 81(4):652. PubMed ID: 9598656
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P; Tincello DG; Richmond DH
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxybutynin for detrusor instability with adjuvant salivary stimulant pastilles to improve compliance: results of a multicentre, randomized controlled trial.
    Tincello DG; Adams EJ; Sutherst JR; Richmond DH
    BJU Int; 2000 Mar; 85(4):416-20. PubMed ID: 10691817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical instillation of oxybutynin in women with idiopathic detrusor instability: a randomised trial.
    Enzelsberger H; Helmer H; Kurz C
    Br J Obstet Gynaecol; 1995 Nov; 102(11):929-30. PubMed ID: 8534633
    [No Abstract]   [Full Text] [Related]  

  • 5. Case 7: the addled nonagenarian.
    Shader RI; Oesterheld JR
    J Clin Psychopharmacol; 1995 Oct; 15(5):378. PubMed ID: 8830074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terodiline and oxybutynin in detrusor instability.
    Drug Ther Bull; 1988 May; 26(10):37-8. PubMed ID: 3383752
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of driptan (oxybutinin) in patients with urgent forms of urination disorders].
    Loran OB; Pushkar' DIu; Tevlin KP
    Urol Nefrol (Mosk); 1998; (6):24-6. PubMed ID: 10051823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxybutinin versus propantheline in the management of detrusor instability. A patient-regulated variable dose trial.
    Holmes DM; Montz FJ; Stanton SL
    Br J Obstet Gynaecol; 1989 May; 96(5):607-12. PubMed ID: 2667633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

  • 12. Advances in anticholinergic therapy delivery systems.
    Davila GW
    Geriatrics; 2002 May; 57 Suppl 1():29-34. PubMed ID: 12040601
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled study.
    Moore KH; Goldstein M; Hay D
    Br J Obstet Gynaecol; 1990 Nov; 97(11):1063-4. PubMed ID: 2082973
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity.
    Salvatore S; Khullar V; Cardozo L; Milani R; Athanasiou S; Kelleher C
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):237-41. PubMed ID: 15808387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy of salivary gland hypofunction.
    Fox PC
    J Dent Res; 1987 Feb; 66 Spec No():689-92. PubMed ID: 3476633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Abrams P; Cardozo L; Chapple C; Serdarevic D; Hargreaves K; Khullar V;
    Int J Urol; 2006 Jun; 13(6):692-8. PubMed ID: 16834644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
    Kilic N; Balkan E; Akgoz S; Sen N; Dogruyol H
    Int J Urol; 2006 Feb; 13(2):105-8. PubMed ID: 16563131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
    Goldenberg MM
    Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal oxybutynin (oxytrol) for urinary incontinence.
    Dull P
    Am Fam Physician; 2004 Dec; 70(12):2351-2. PubMed ID: 15617300
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term administration study of propiverine hydrochloride (BUP-4 tablets) in pollakiuria and urinary incontinence].
    Noguchi K; Masuda M; Noguchi S; Kubota Y; Hosaka M; Senga Y; Sano K; Miyai K; Kanno H; Kitami K; Fujinami K; Miura T; Kondo I; Kawasaki C; Moriyama M; Hara Y; Ida T; Fukuoka H; Nakagawa J; Kitajima N; Fukuda M; Satomi Y; Takahashi T; Yamaguchi T; Shiozaki H
    Hinyokika Kiyo; 1998 Sep; 44(9):687-93. PubMed ID: 9805679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.